Privileging pharmacists improves time to patient notification in the microbiological test review process for patients discharged from the emergency department

Autor:	Steven M. Loborec, Jose A. Bazan, Mary Beth Shirk, Trisha A. Jordan, Nicole V. Brown
Rok vydání:	2020
Předmět:	Microbiological Techniques medicine.medical_specialty Time Factors Statistical difference Psychological intervention Pharmacist Specialty Credentialing Pharmacists 03 medical and health sciences 0302 clinical medicine Professional Role Anti-Infective Agents Medicine Humans Review process 030212 general & internal medicine Retrospective Studies Pharmacology Academic Medical Centers business.industry Health Policy 030208 emergency & critical care medicine Emergency department Patient Discharge Test (assessment) Emergency medicine business Emergency Service Hospital Pharmacy Service Hospital
Zdroj:	American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 77(Supplement_1)
ISSN:	1535-2900
Popis:	Purpose Results of a study evaluating the impact of privileging pharmacists to manage microbiologic test results for patients discharged from the emergency department (ED) are reported. Methods This was a single-center, retrospective pre-post study that was conducted at an urban academic medical center. Patients discharged from the ED with a subsequent positive microbiologic test result before and after privileging of an ED specialty practice pharmacist (ED-SPP) to manage the results independently were screened for inclusion. Time to patient notification of a required change in antimicrobial therapy was compared between groups. Numbers of erroneous interventions before and after pharmacist privileging were compared to assess the safety of implementation. Results One hundred seventy-eight positive microbiologic test results (n = 92 pre- and n = 86 postimplementation) were included. The median time to patient notification in the pre-implementation group was 23.6 hours (range, 12.4-93 hours) and in the postimplementation group was 14.9 hours (range, 2.5-27.9 hours; P = 0.0023). As determined by the board-certified infectious disease physician, 1.1% of reviewed microbiologic test results (1 of 92) was erroneous prior to implementation of pharmacist privileging compared with 2.3% (2 of 86) after implementation (P = 0.6105). Conclusion Privileging ED-SPPs to assess microbiologic test results improved the time to patient notification with no statistical difference in the number of erroneous interventions between groups. These findings demonstrate the benefit of clinical privileging and provide support for expansion of this role to other ED-SPPs.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfff1051901ffcf8030b7d2e602d5dd https://pubmed.ncbi.nlm.nih.gov/31960026 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.